Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?

Publication:
Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?

cris.virtualsource.author-orcid	8596fee5-4d7b-45b0-89f4-b464fac81857
datacite.rights	open.access
dc.contributor.author	Marinoni, Ilaria
dc.date.accessioned	2024-10-06T19:07:32Z
dc.date.available	2024-10-06T19:07:32Z
dc.date.issued	2022-05
dc.description.numberOfPages	2
dc.description.sponsorship	Institut für Pathologie
dc.identifier.doi	10.48350/162069
dc.identifier.pmid	33975869
dc.identifier.publisherDOI	10.1136/gutjnl-2021-324664
dc.identifier.uri	https://boris-portal.unibe.ch/handle/20.500.12422/58163
dc.language.iso	en
dc.publisher	BMJ Publishing Group
dc.relation.ispartof	Gut
dc.relation.issn	0017-5749
dc.relation.organization	Institute of Tissue Medicine and Pathology
dc.subject	neuroendocrine cells neuroendocrine tumors pancreatic endocrine tumour pancreatic islet cell
dc.subject.ddc	500 - Science::570 - Life sciences; biology
dc.subject.ddc	600 - Technology::610 - Medicine & health
dc.title	Prognostic value of DAXX/ATRX loss of expression and ALT activation in PanNETs: is it time for clinical implementation?
dc.type	article
dspace.entity.type	Publication
dspace.file.type	text
oaire.citation.endPage	848
oaire.citation.issue	5
oaire.citation.startPage	847
oaire.citation.volume	71
oairecerif.author.affiliation	Institut für Pathologie
unibe.contributor.role	creator
unibe.date.licenseChanged	2021-12-21 09:26:00
unibe.description.ispublished	pub
unibe.eprints.legacyId	162069
unibe.journal.abbrevTitle	GUT
unibe.refereed	true
unibe.subtype.article	contribution

Now showing 1 - 1 of 1